Efficacy of SCH27899 in an Animal Model of Legionnaires' Disease Using Immunocompromised A/J Mice

The efficacy of SCH27899, a new everninomicin antibiotic, against replicative Legionella pneumophila lung infections in an immunocompromised host was evaluated using a murine model of Legionnaires' disease. A/J mice were immunocompromised with cortisone acetate and inoculated intratracheally with L....

全面介紹

書目詳細資料

發表在:	Antimicrob Agents Chemother
Principais autores:	Brieland, Joan K., Loebenberg, David, Menzel, Fred, Hare, Roberta S.
格式:	Artigo
語言:	Inglês
出版:	American Society for Microbiology (ASM) 2000
主題:	Experimental Therapeutics
在線閱讀:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89864/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10770771/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.5.1333-1336.2000
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!